March 19, 2015
The Federal Trade Commission filed a letter in Pennsylvania federal court on Wednesday saying some discovery was needed on a motion for summary judgment that was filed by AbbVie Inc., Abbott Laboratories and two others before answering the complaint or moving to dismiss in the new Androgel pay-for-delay suit.
September 08, 2014
The Federal Trade Commission accused AbbVie Inc. on Monday of keeping Teva Pharmaceuticals USA Inc.'s generic AndroGel off the market through a side licensing deal, and experts say the watchdog's first pay-for-delay case since its 2013 U.S. Supreme Court win is already stretching the boundaries the justices laid out for antitrust claims under that landmark decision.